EUVIMEDEUVIMED entdecken
Open Access

Impact of antiallergy agents on CPAP therapy and sleep quality with spring pollinosis in Japanese

Akihisa Yoshikawa, Ayako Inoshita iD, Naoko Sata, Masahiro Nakamura, Yo Suzuki, Erina Ishimizu, Shoko Suda, Ryo Naito, Takatoshi Kasai, Fumihiko Matsumoto

Sleep and Breathing · 2023

DOI: 10.1007/s11325-023-02788-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Sleep and Breathing, 2023. Verfasst von Akihisa Yoshikawa und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, Head and Neck Surgery, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Tokyo, Bunkyo-Ku, 113-8421, J…. Hauptthemen laut MEDLINE: Rhinitis, Allergic, Seasonal, Anti-Allergic Agents, Nasal Obstruction, Sleep Apnea, Obstructive. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Allergic rhinitis (AR) is associated with obstructive sleep apnea (OSA) and nasal obstruction causes decreased adherence to continuous positive airway pressure (CPAP). The purpose is to evaluate the effects of antiallergic agents on CPAP adherence and sleep quality. METHODS: A longitudinal study was made of patients who use CPAP for OSA and treated with antiallergy agents for spring pollinosis. We compared the Pittsburgh Sleep Quality Index (PSQI), Epworth Sleepiness Scale (ESS), nasal symptoms scores (NSS), and data from CPAP before and after treatment. Then, we classified the subjects into two groups based on the baseline PSQI score: one group without a decreased sleep quality (PSQI < 6) and the other group with decreased sleep quality (PSQI ≥ 6). RESULTS: Of 28 subjects enrolled, 13 had good sleep quality and 15 had poor sleep quality. PSQI showed significant improvements after medication (p = 0.046). ESS showed no significant differences after AR medication (p = 0.565). Significant improvement was observed after the prescription of antiallergy agents in all items of NSS (sneezing, p < 0.05; rhinorrhea, p < 0.01; nasal obstruction, p < 0.01; QOL, p < 0.01). The percentage of days with CPAP use more than 4 h increased significantly after the administration of rhinitis medication (p = 0.022). In the intragroup comparisons of PSQI ≥ 6 group, PSQI decreased significantly (p < 0.05). For the NSS in intragroup comparisons of PSQI ≥ 6 group, all parameters showed significant improvement (sneezing, p = 0.016; rhinorrhea, p = 0.005; nasal obstruction, p < 0.005; QOL, p < 0.005). CONCLUSION: The use of antiallergy agents can improve CPAP adherence and sleep quality in patients with OSA on CPAP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rhinitis, Allergic, SeasonalAnti-Allergic AgentsNasal ObstructionSleep Apnea, ObstructiveHumansContinuous Positive Airway PressureSleep QualityLongitudinal StudiesQuality of LifeSneezingEast Asian PeopleRhinorrheaPatient Compliance

Stichwörter der Autor:innen

Allergic rhinitisAntiallergic agentsCPAP adherenceObstructive sleep apneaSleep quality

Substanzen

Anti-Allergic Agents

Autor:innen und Institutionen

  • Department of Otorhinolaryngology, Head and Neck Surgery, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Tokyo, Bunkyo-Ku, 113-8421, Japan.
  • Sleep and Sleep-Disordered Breathing Center, Juntendo University Hospital, Tokyo, Japan.
  • Department of Otorhinolaryngology, Head and Neck Surgery, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Tokyo, Bunkyo-Ku, 113-8421, Japan. ayaent@juntendo.ac.jp.
  • Sleep and Sleep-Disordered Breathing Center, Juntendo University Hospital, Tokyo, Japan. ayaent@juntendo.ac.jp.
  • Department of Cardiovascular Biology and Medicine , Juntendo University Graduate School of Medicine, Tokyo, Japan.
  • Cardiovascular Respiratory Sleep Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.

ORCID-Profile: Ayako Inoshita

Zitieren

APA

Yoshikawa, A., Inoshita, A., Sata, N., Nakamura, M., Suzuki, Y., Ishimizu, E., Suda, S., Naito, R., Kasai, T., & Matsumoto, F. (2023). Impact of antiallergy agents on CPAP therapy and sleep quality with spring pollinosis in Japanese. Sleep and Breathing. https://doi.org/10.1007/s11325-023-02788-2

Vancouver

Yoshikawa A, Inoshita A, Sata N, Nakamura M, Suzuki Y, Ishimizu E, et al. Impact of antiallergy agents on CPAP therapy and sleep quality with spring pollinosis in Japanese. Sleep and Breathing. 2023. doi:10.1007/s11325-023-02788-2

BibTeX
@article{Yoshikawa2023,
  author = {Yoshikawa, Akihisa and Inoshita, Ayako and Sata, Naoko and Nakamura, Masahiro and Suzuki, Yo and Ishimizu, Erina and Suda, Shoko and Naito, Ryo and Kasai, Takatoshi and Matsumoto, Fumihiko},
  title = {Impact of antiallergy agents on CPAP therapy and sleep quality with spring pollinosis in Japanese},
  journal = {Sleep and Breathing},
  year = {2023},
  doi = {10.1007/s11325-023-02788-2}
}
Kostenlos starten →